Press release
Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight
Angioedema Market
DelveInsight's "Angioedema Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Angioedema, historical and forecasted epidemiology as well as the Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of Angioedema Market Report are:
• HAE in the US has been observed with the maximum number of diagnosed cases in the age-group 17 to below 65 years, followed by those who belong to the age-group 12 to less than 17 years. DelveInsight's analysts have estimated that there were 882 cases diagnosed for the age group 17 to below 65 years in 2017, among the US population, which is predicted to increase consistently throughout the study period.
• Among the European countries, France had the highest prevalent population of 1,346 cases, followed by the UK which had prevalent population of 1,301 in 2017.
• Type 1 HAE (98.73%) accounted for the majority of Chinese HAE patients, while no type 3 HAE patient has been diagnosed in China to date (Liu et al, 2019).
• According to DelveInsight's analysis, HAE is more prominent in females in comparison to males.
To know more details about Angioedema Market Report, Click here: https://www.delveinsight.com/report-store/angioedema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Angioedema Market Report
• The report covers the descriptive overview of Angioedema, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Angioedema epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Angioedema is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of the Angioedema market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Angioedema market
To know more details of Angioedema Market Report, Click here: https://www.delveinsight.com/report-store/angioedema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of Angioedema Drugs are:
• Lanadelumab
• C1 inhibitor concentrate (C1-esteraseremmer-N)
• Icatibant
• Omalizumab
• KVD824
• And Many Others
Some of the Angioedema Companies are:
• Takeda
• Shire Pharmaceuticals
• Prothya Biosolutions
• Novartis
• KalVista Pharmaceuticals
• And Many Others
To know more details about Angioedema Pipeline drugs and Therapies, Click here: https://www.delveinsight.com/report-store/angioedema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
1. Key Insights
2. Executive Summary of Angioedema
3. Competitive Intelligence Analysis for Angioedema
4. Angioedema: Market Overview at a Glance
5. Angioedema: Disease Background and Overview
6. Patient Journey
7. Angioedema Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Angioedema Unmet Needs
10. Key Endpoints of Angioedema Treatment
11. Angioedema Marketed Products
12. Angioedema Emerging Therapies
13. Angioedema: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Angioedema
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Request for Sample to get detailed TOC: https://www.delveinsight.com/report-store/angioedema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Reports:
Bacteremia Market
https://www.delveinsight.com/report-store/bacteremia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Central Retinal Vein Occlusion Market
https://www.delveinsight.com/report-store/central-retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Chondrosarcoma Market
https://www.delveinsight.com/report-store/chondrosarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Microsatellite Stable Colorectal Cancer Market
https://www.delveinsight.com/report-store/microsatellite-stable-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Progressive Multifocal Leukoencephalopathy Market
https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Prosthetic Joint Infection Market
https://www.delveinsight.com/report-store/prosthetic-joint-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Higher-Risk Chronic Myelomonocytic Leukemia Market
https://www.delveinsight.com/report-store/higher-risk-chronic-myelomonocytic-leukemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Upper Limb Hypertonia Market
https://www.delveinsight.com/report-store/upper-limb-hypertonia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
X-linked Retinitis Pigmentosa Market
https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Metachromatic Leukodystrophy Market
https://www.delveinsight.com/report-store/metachromatic-leukodystrophy-mld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Idiopathic Membranous Nephropathy Market
https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Nevoid Basal Cell Carcinoma Syndrome Market
https://www.delveinsight.com/report-store/nevoid-basal-cell-carcinoma-syndrome-nbccs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Chronic Refractory Cough Market
https://www.delveinsight.com/report-store/chronic-refractory-cough-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cardiopulmonary Bypass Equipment Market
https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cardiac Biomarkers Testing Devices Market
https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Epithelial Ovarian Cancer Market
https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Surgical Site Infection Ssi Market
https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Keloid Market
https://www.delveinsight.com/report-store/keloid-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Synchronous Endometrial And Ovarian Carcinoma Market
https://www.delveinsight.com/report-store/synchronous-endometrial-and-ovarian-cancer-seoc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Autosomal Recessive Congenital Ichthyosis Market
https://www.delveinsight.com/report-store/autosomal-recessive-congenital-ichthyosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Rituximab Biosimilars Insight
https://www.delveinsight.com/report-store/rituximab-biosimilars-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Adamantinoma Market
https://www.delveinsight.com/report-store/adamantinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Hpv-induced Cancers Market
https://www.delveinsight.com/report-store/hpv-induced-cancers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pain Management Devices Market
https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Continuous Renal Replacement Therapy Machines Market
https://www.delveinsight.com/report-store/continuous-renal-replacement-therapy-machines-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Parkinsons Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
22q11.2 Deletion Syndrome Market
https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pediatric Growth Hormone Deficiency Pghd Market
https://www.delveinsight.com/report-store/pediatric-growth-hormone-deficiency-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Brain Aneurysm Stents Market
https://www.delveinsight.com/report-store/brain-aneurysm-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Dermal Erythema Market
https://www.delveinsight.com/report-store/dermal-erythema-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pelvic Inflammatory Disease Market
https://www.delveinsight.com/report-store/pelvic-inflammatory-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Polypoidal Choroidal Vasculopathy Market
https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports as well as customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight here
News-ID: 2615577 • Views: …
More Releases from DelveInsight Business Research
Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA App …
The "Vitiligo Pipeline Insight, 2025" report by DelveInsight delivers an in-depth view of the current clinical development scenario along with the future growth trajectory of the Vitiligo Market.
As per DelveInsight's evaluation, the global Vitiligo treatment pipeline features 20+ leading companies actively engaged in developing 20+ therapeutic candidates. The analysis covers Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and developmental updates.
The Vitiligo Pipeline report offers extensive commercial and clinical…
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Th …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Myelodysplastic Syndrome Pipeline Report
• DelveInsight's Myelodysplastic Syndrome…
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA …
According to DelveInsight, the global Fibromyalgia pipeline features more than eight key companies actively developing over ten treatment candidates. The analysis encompasses ongoing clinical trials, therapeutic mechanisms of action, routes of administration, and recent developments within the Fibromyalgia treatment landscape.
The Fibromyalgia Pipeline 2025 report provides an exhaustive evaluation of pipeline products, ranging from preclinical stages to marketed therapies. It includes comprehensive details on each drug's mechanism of action, clinical trial…
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, F …
As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 7+ key companies continuously working towards developing 8+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Chronic Wounds Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Wounds Market.
The Chronic Wounds Pipeline report embraces in-depth commercial and clinical assessment…
More Releases for Angioedema
Hereditary Angioedema Market: An In-Depth Analysis
In 2024, the market for Hereditary Angioedema Market was valued at USD 3.1 billion. It is anticipated to grow to USD 5.9 billion by 2033, with a CAGR of 6.82% over the period 2026-2033.
Hereditary Angioedema Market Overview
The global hereditary angioedema therapeutics market is experiencing significant expansion, driven by increasing awareness, improved diagnostic capabilities, and the introduction of novel treatment options. Advances in genetic research have enabled early and accurate…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Global Hereditary Angioedema Market report from Global Insight Services is the single authoritative source of intelligence on hereditary angioedema market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…
Angioedema Treatment Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Angioedema Treatment market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This report is…
Hereditary Angioedema Therapeutics Market - Forecast to 2026
As per the research conducted by GME, the Global Hereditary Angioedema Therapeutics Market will grow with a CAGR value of 8.2%. Population growth, as well as lifestyle changes, improved insurance programs, and increased efforts by pharmaceutical and biotechnology companies to develop new products and solutions for the industry, are expected to fuel market revenue for Hereditary Angioedema in the years ahead.
Browse 153 Market Data Tables and 113 Figures spread through…
